Rigel Pharma (RIGL) Reports In-Line Q4 EPS
Tweet
Share
E-mailGet Alerts RIGL Hot Sheet
Price: $42.45 -0.31%
Financial Fact:
Income (loss) from operations: -22.74M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Income (loss) from operations: -22.74M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Rigel Pharma (NASDAQ: RIGL) reported Q4 EPS of ($0.13), in-line with the analyst estimate of ($0.13). Revenue for the quarter came in at $20.4 million versus the consensus estimate of $21.9 million.
For earnings history and earnings-related data on Rigel Pharma (RIGL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla to launch Cybercab in Austin this month - report
- InspireMD (NSPR) Tops Q2 EPS by 1c
- XP Inc eyes US banking license as next business step
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
